Escalon Medical Corp. (Escalon) operates in the healthcare market, engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company operates in two segments: Sonomed-Escalon and Escalon Medical Corp. (Corporate). The Sonomed-Escalon segment includes Sonomed, Inc., Escalon Digital Solutions, Inc. (EMI) and Trek, Inc. (Trek), which are engaged in the development and sale of ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations. The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The development of ultrasound ophthalmic equipment is performed at the Company's Lake Success, New York and Stoneham, Massachusetts facilities. The Company leases approximately 11,250 square feet of space in Wisconsin, for its surgical products.
|Headquarters||435 Devon Park Dr Ste 100|
WAYNE, PA, United States 19087-1942
|Chairman of the Board||Richard DePiano|
|President, General Counsel, Director||Richard DePiano|
|Chief Financial Officer||Robert O'Connor|
|Chief Operating Officer||Mark Wallace|
|Director||C. Todd Trusk|
|Shares Out.||7.5M||Book Value||$0.40|
|Annual Dividend Rate||0.00 USD||Price/Sales (TTM)||0.4|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||-9.63%|
*GAAP = prior to non-GAAP analyst adjusted earnings.